CSL Behring: CSL Behring Says HEMGENIX Receives Positive Canada Reimbursement Decision
CANBERA (dpa-AFX) - CSL Behring Canada Inc., a business unit of Australian biotechnology company CSL Ltd. (CSL.AX, CMXHF.PK), announced Tuesday that the Canadian Agency for Drugs and Technologies ...
Read full article »
CSL Behring is a Pennsylvania-based biopharmaceutical company that develops protein-based therapies for the treatment of bleeding disorders and pulmonary disease.
Read more